المؤلفون: Udrea, Anghel Adrian, Yamaguchi, Kensei, Hitre, Erika, Cardellino, Giovanni Gerardo, Saeed, Anwaar, Kang, Yoon-Koo, Catenacci, Daniel V. T., Wainberg, Zev A., Enzinger, Peter C., Yang, Yingsi, Mitra, Siddhartha, Guardeno, Raquel, Qin, Shukui, Lee, Keun-Wook, Kim, In-Ho, Oh, Sang Cheul, Li, Jin, Turk, Haci M., Teixeira, Alexandra Carolina, Borg, Christophe

مصطلحات موضوعية: Catenacci D. V. T., Kang Y., Saeed A., Yamaguchi K., Qin S., Lee K., Kim I., Oh S. C., Li J., Turk H. M., et al., FIGHT: A randomized, double-blind, placebo-controlled, phase II study of bemarituzumab (bema) combined with modified FOLFOX6 in 1L FGFR2b+advanced gastric/gastroesophageal junction adenocarcinoma (GC).-, JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.15

Time: 2021

Relation: http://hdl.handle.net/20.500.12645/29666; WOS:000708120602112

الاتاحة: https://hdl.handle.net/20.500.12645/29666
https://doi.org/10.1200/jco.2021.39.15_suppl.4010